Concepedia

Vaibhav G. Patel

VG

Statistics

Publications

14

Citations

1.5K

H-Index

11

Active since

2016

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

The Ohio State University

University of California San Diego

Memorial Sloan Kettering Cancer Center

Vaibhav G. Patel is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2016–2023

14

Publications

14

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Andrew A. Davis, Vaibhav G. Patel · Journal for ImmunoTherapy of Cancer · 2019 · 930 citations · Full text

, , +17

Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes

Matthew D. Galsky, Huan Wang, Noah M. Hahn et al. · European Urology · 2017 · 113 citations

, , +8

Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition

Ana Collazo-Lorduy, Mireia Castillo-Martín, Li Wang et al. · European Urology · 2016 · 88 citations · Full text

, , +10

<i>CDK12</i>-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade

Michael T. Schweizer, Gavin Ha, Roman Gulati et al. · JCO Precision Oncology · 2020 · 88 citations · Full text

Accelerating precision medicine in metastatic prostate cancer

Joaquı́n Mateo, Rana R. McKay, Wassim Abida et al. · Nature Cancer · 2020 · 76 citations · Full text

, , +2

1–5 of 14